1. Home
  2. CRWS vs IGC Comparison

CRWS vs IGC Comparison

Compare CRWS & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crown Crafts Inc

CRWS

Crown Crafts Inc

HOLD

Current Price

$2.77

Market Cap

29.4M

ML Signal

HOLD

Logo IGC Pharma Inc.

IGC

IGC Pharma Inc.

HOLD

Current Price

$0.29

Market Cap

28.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRWS
IGC
Founded
1957
2005
Country
United States
United States
Employees
N/A
70
Industry
Textiles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.4M
28.9M
IPO Year
1994
2005

Fundamental Metrics

Financial Performance
Metric
CRWS
IGC
Price
$2.77
$0.29
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.25
AVG Volume (30 Days)
19.4K
487.7K
Earning Date
02-11-2026
03-19-2026
Dividend Yield
11.49%
N/A
EPS Growth
N/A
59.09
EPS
N/A
N/A
Revenue
$70,270,000.00
$1,271,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$13.06
P/E Ratio
N/A
N/A
Revenue Growth
6.51
N/A
52 Week Low
$2.35
$0.24
52 Week High
$3.38
$0.50

Technical Indicators

Market Signals
Indicator
CRWS
IGC
Relative Strength Index (RSI) 48.21 42.88
Support Level $2.72 $0.28
Resistance Level $2.87 $0.31
Average True Range (ATR) 0.07 0.01
MACD -0.00 -0.00
Stochastic Oscillator 27.79 23.29

Price Performance

Historical Comparison
CRWS
IGC

About CRWS Crown Crafts Inc

Crown Crafts Inc operates in the infant and toddler products segment of the consumer products industry through its wholly-owned subsidiaries. The infant and toddler products segment consists of infant and toddler bedding, bibs, soft bath products, disposable products, and accessories. The company serves a diverse range of customers including mass merchants, mid-tier retailers, juvenile specialty stores, value channel stores, grocery and drug stores, restaurants, internet accounts, wholesale clubs, and internet-based retailers. The company's brands include NoJo, Neat Solutions, Sassy, and Carousel. Its products are marketed under a variety of company-owned trademarks, under trademarks licensed from others, and as private-label goods.

About IGC IGC Pharma Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

Share on Social Networks: